JPS5917990A - 微生物由来の精製されたピリジン可溶性抽出物及びその製造方法、並びに該抽出物を含有する医薬 - Google Patents

微生物由来の精製されたピリジン可溶性抽出物及びその製造方法、並びに該抽出物を含有する医薬

Info

Publication number
JPS5917990A
JPS5917990A JP58116248A JP11624883A JPS5917990A JP S5917990 A JPS5917990 A JP S5917990A JP 58116248 A JP58116248 A JP 58116248A JP 11624883 A JP11624883 A JP 11624883A JP S5917990 A JPS5917990 A JP S5917990A
Authority
JP
Japan
Prior art keywords
pyridine
micrograms
soluble extract
composition
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58116248A
Other languages
English (en)
Japanese (ja)
Inventor
ジヨン・エル・キヤントレル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIBI IMUNOCHIEMU RESEARCH Inc
Original Assignee
RIBI IMUNOCHIEMU RESEARCH Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIBI IMUNOCHIEMU RESEARCH Inc filed Critical RIBI IMUNOCHIEMU RESEARCH Inc
Publication of JPS5917990A publication Critical patent/JPS5917990A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/15Corynebacterium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32Mycobacterium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365Nocardia

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58116248A 1982-06-30 1983-06-29 微生物由来の精製されたピリジン可溶性抽出物及びその製造方法、並びに該抽出物を含有する医薬 Pending JPS5917990A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39382182A 1982-06-30 1982-06-30
US393821 1982-06-30

Publications (1)

Publication Number Publication Date
JPS5917990A true JPS5917990A (ja) 1984-01-30

Family

ID=23556385

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58116248A Pending JPS5917990A (ja) 1982-06-30 1983-06-29 微生物由来の精製されたピリジン可溶性抽出物及びその製造方法、並びに該抽出物を含有する医薬

Country Status (6)

Country Link
JP (1) JPS5917990A (it)
CA (1) CA1209504A (it)
DE (1) DE3323094A1 (it)
FR (1) FR2534271B1 (it)
GB (1) GB2123006B (it)
IT (1) IT1163622B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8640414B2 (en) 2006-05-24 2014-02-04 II Robert A. Reyes Fully insulated glass panel rolling door

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663306A (en) * 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5624513A (en) * 1979-08-03 1981-03-09 Mitsubishi Heavy Ind Ltd Composite displaying device for navigation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
NL7308450A (it) * 1972-06-20 1973-12-27
US3976544A (en) * 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白wenac及びその製造法
JPS57165320A (en) * 1981-04-06 1982-10-12 Sanraku Inc Antitumor agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5624513A (en) * 1979-08-03 1981-03-09 Mitsubishi Heavy Ind Ltd Composite displaying device for navigation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8640414B2 (en) 2006-05-24 2014-02-04 II Robert A. Reyes Fully insulated glass panel rolling door

Also Published As

Publication number Publication date
FR2534271B1 (fr) 1988-06-17
DE3323094A1 (de) 1984-01-05
FR2534271A1 (fr) 1984-04-13
GB2123006B (en) 1985-08-29
GB8317743D0 (en) 1983-08-03
GB2123006A (en) 1984-01-25
IT8321852A0 (it) 1983-06-29
IT8321852A1 (it) 1984-12-29
IT1163622B (it) 1987-04-08
DE3323094C2 (it) 1988-09-29
CA1209504A (en) 1986-08-12

Similar Documents

Publication Publication Date Title
DE3318567C2 (de) Therapeutisches Mittel, enthaltend gereinigtes, entgiftetes Endotoxin, Zellwandgerüst und Trehalosedimycolat
DE3833319C2 (it)
JPS58216121A (ja) 精製無毒化エンドトキシン及びその製造方法
JP2648305B2 (ja) 多糖類ワクチン
DE3434766C2 (de) Pharmazeutisches Präparat
JPS58222027A (ja) 精製無毒化エンドトキシンを含有する抗腫瘍組成物
US4931275A (en) Anti-tumor vaccines and their preparation
US4505899A (en) Refined detoxified endotoxin product
US4504473A (en) Pyridine soluble extract of a microorganism
DE69014543T2 (de) Multivalentes immunogen lmi.
US4543253A (en) Solidified pharmaceutical composition comprising cell wall skeleton
JPS5917990A (ja) 微生物由来の精製されたピリジン可溶性抽出物及びその製造方法、並びに該抽出物を含有する医薬
US4505903A (en) Pyridine soluble extract of a microorganism
US4503048A (en) Pyridine soluble extract of a microorganism
JPS601133A (ja) 微生物由来の精製されたピリジン可溶性抽出物を含有する医薬組成物
JPS5917991A (ja) 微生物由来の精製されたピリジン可溶性抽出物を含有する医薬組成物
US4613504A (en) Pyridine-soluble extracts of microorganisms
JPH0651109B2 (ja) 脂質膜構造体
GB2120548A (en) Anti-tumour microorganism obtained products
KR820000420B1 (ko) 세포의 벽조직을 구성하는 고형화된 제약 조성물의 제조방법
JPH06293650A (ja) サイトカイン誘導剤
JPS6129716B2 (it)
JPH10276790A (ja) 腸内菌及びレイ菌による、腫瘍細胞及び腫瘍産生物の 分解による抗腫瘍物質の合成法及び精製法について